Current price is more than the intrinsic value

Intrinsic Value

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Suven Pharmaceuticals Ltd is a mid-cap company having a market cap of ₹12,504.23 Crore operating in the pharma sector

This multibagger stock shall pay 600% dividend soon: Do you own it?

NELCO Ltd, Aegis Logistics Ltd, Surya Roshni Ltd and Suven Pharmaceuticals Ltd are among the other gainers in the BSE’s ‘A’ group today, 29 August 2022.

Mazagon Dock Shipbuilders Ltd leads gainers in ‘A’ group

Suven Pharma Q1 Review - CRAMs Continue To Deliver, Outlook Stable: ICICI Direct

The US Food and Drug Administration (USFDA) completed a pre-approval inspection at Casper Pharma formulations manufacturing facility situated at GMR Hyderabad SEZ.

Suven Pharma says Casper Pharma completes USFDA pre-approval inspection

Broker’s call: Suven Pharma (Accumulate)

Suven Pharma - CDMO Core Growth Intact; Formulations To Pick Up: Anand Rathi

Suven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 13147.01 Crore) operating in Pharmaceuticals sector.

Buy Suven Pharmaceuticals, target price Rs 627: Anand Rathi

Suven Pharma Consolidated March 2022 Net Sales at Rs 363.85 crore, up 40.39% Y-o-Y

The company had reported a profit after tax (PAT) of Rs 83 crore in the January-March quarter of 2020-21 fiscal.

Suven Pharma Q4 net up 11% at Rs 92 crore | The Financial Express

UPL, PVR, Godrej Agrovet, Infibeam Avenues, Dalmia Bharat, 3i Infotech, Aarti Drugs, BASF India, Borosil, Central Bank of India, CMS Info Systems, Craftsman Automation, Vedant Fashions, Suven Pharmaceuticals are among the key companies scheduled to release their quarterly earnings today

Stocks to Watch: Reliance Industries, HCL Tech, LTI, Mindtree, Tata Power

Suven will purchase100% of share capital from CPPL existing investors. Suven didn’t provide details like annual turnover of the acquired asset citing that CPPL is yet to reach commercially viable operations.

Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 crore

Suven Pharmaceuticals is engaged in  Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development

Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

This multibagger stock shall pay 600% dividend soon: Do you own it?

Mazagon Dock Shipbuilders Ltd leads gainers in ‘A’ group

Suven Pharma Q1 Review - CRAMs Continue To Deliver, Outlook Stable: ICICI Direct

Suven Pharma says Casper Pharma completes USFDA pre-approval inspection

Broker’s call: Suven Pharma (Accumulate)

Suven Pharma - CDMO Core Growth Intact; Formulations To Pick Up: Anand Rathi

Buy Suven Pharmaceuticals, target price Rs 627: Anand Rathi

Suven Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

This multibagger stock shall pay 600% dividend soon: Do you own it?

Mazagon Dock Shipbuilders Ltd leads gainers in ‘A’ group

Suven Pharma Q1 Review - CRAMs Continue To Deliver, Outlook Stable: ICICI Direct

Suven Pharma says Casper Pharma completes USFDA pre-approval inspection

Broker’s call: Suven Pharma (Accumulate)

Suven Pharma - CDMO Core Growth Intact; Formulations To Pick Up: Anand Rathi

Buy Suven Pharmaceuticals, target price Rs 627: Anand Rathi

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock